Plasmacytoid dendritic cells (pDCs) are present in peripheral blood, leptomeninges and demyelinating lesions in patients with multiple sclerosis (MS). The ability of pDCs to produce chemokines and express the chemokine receptor CCR7 in MS is not known. We studied pDCs in MS patients and healthy subjects. The ability of pDCs to up-regulate CCR7 was significantly increased in untreated MS patients as compared to healthy subjects. IFN-beta treatment significantly inhibited TLR9 agonist-specific secretion of chemokines, which are ligands for CCR5-positive Th1 cells (CCL3, CCL4, and CCL5), and impaired TLR9 agonist-induced up-regulation of CCR7 and IFN-alpha in MS patients. This finding represents a new immunomodulatory effect of IFN-beta in patients with multiple sclerosis.
Introduction
Multiple sclerosis (MS) is considered to be an immune-mediated disorder of the central nervous system (CNS) (McFarland and Martin, 2007; Sospedra and Martin, 2005) . Although the immunopathogenesis of the disease is not completely understood, both polygenic and environmental factors contribute to disease onset and/or clinical exacerbation (Hafler et al., 2007; Noseworthy et al., 2000; Compston and Coles, 2002) . Viral pathogens have been implicated in the etiology and pathogenesis of MS (reviewed in Cook et al., 1996) . Among those, strong data implicates Epstein-Barr Virus (EBV) a human DNA virus (Haahr and Hollsberg, 2006; Serafini et al., 2007; Giovannoni et al., 2006; Levin et al., 2003; Ascherio and Munger, 2008) . The association of HHV-6 with MS has been suggested and is being investigated (Swanborg et al., 2003) . For established MS patients, the risk of disease exacerbation was found to be increased at the time or shortly after clinical viral infections (Edwards et al., 1998; Sibley et al., 1985; Panitch, 1994) (and reviewed by Rutschmann et al., 2002) . In addition to infection, the antiviral protein interferon (IFN)-gamma, a T helper type 1 (Th1)-type cytokine produced mainly by NK and T cells, is able to trigger multiple sclerosis exacerbation (Panitch et al., 1987a,b) .
Plasmacytoid dendritic cells (pDCs), characterized as CD11c(−)Lin (−)CD123(++)DR(++)BDCA2(+)BDCA4(+)cells, have been intensively investigated due to their important role in both innate and adaptive immunity (Colonna et al., 2004; Gilliet et al., 2008; Fitzgerald-Bocarsly et al., 2008) . Compared to other peripheral blood mononuclear cells, pDCs express a high level of Toll-like receptor 9 (TLR9) (Liu, 2005) which recognizes viral DNA within the early endosomes at the initial phase of viral infection. Activated via TLR9, pDCs secrete multiple immunoregulatory cytokines/chemokines such as IFN-Type I cytokines, TNF-alpha, IL-6, CCL3, CCL4, CCL5, CXCL10 and IL-8 (Decalf et al., 2007) and up-regulate expression of chemokine receptor CCR7 directing them to secondary lymph organs to prime naïve T cells (Sozzani et al., 1998) . Among cytokines produced by pDCs are IFN-Type I cytokines promoting Th1 cell differentiation via STAT4 transcriptional factor pathway (reviewed in Korman et al., 2008) , IL-6 which promotes myelin antigen-specific Th17-and Th1-responses in experimental autoimmune encephalomyelitis (EAE) (Serada et al., 2008) , and TNF-alpha which induces oligodendrocyte apoptosis (Akassoglou et al., 1998) and mediates neuronal injury (Iliev et al., 2004) . In addition, pDCs produce chemokines CCL3, CCL4 and CCL5 which are ligands for CCR5 positive T cells secreting high level of IFN-gamma in MS patients (Balashov et al., 1999) . PDCs are found in the CSF of MS patients (Pashenkov et al., 2001 (Pashenkov et al., , 2002 Lopez et al., 2006; Journal of Neuroimmunology 226 (2010) 158-164 
